Full Text (PDF)
Indian Journal of Emergency Medicine 10(3):p 163-166, July-Sept. 2024. | DOI: https://doi.org/10.21088/ijem.2395.311X.10324.10
Case Report
A Rare Case of Hypercalcemia without any Underlying Disease
Saurabh Saini, Abhishek Yadav, Smriti Arora, Kishalay Datta
Author Information
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Indian Journal of Emergency Medicine 10(3):p 163-166, July-Sept. 2024. | DOI: https://doi.org/10.21088/ijem.2395.311X.10324.10
How Cite This Article:
Saini S, Yadav A, Arora S, et al. A rare case of hypercalcemia without any underlying disease. Ind J Emerg Med. 2024;10(3):163-6.Timeline
Received : July 29, 2024
Accepted : August 17, 2024
Published : September 10, 2024
Abstract
Vitamin D supplements and calcium supplements are routinely supplements to infants and females in the Indian subcontinent. However, overdose of these medications can lead to life threatening hypercalcemia. We highlight the risk involved in self-medications of calcium supplements by the public, how various advertisements and publicity abet the consumption of these supplements without any proper medical supervision and how fatal the consumption of these “over the counter” supplements can cause.
References
- 1. Guerra V, Neto OMV, Laurindo AF, Paula FJAD, Neto MM. Hypercalcemia and renal function impairment associated with vitamin D toxicity: case report. Braz J Nephrol. 2016;38(4):466–9.
- 2. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomized trials. Bmj. 2014;348:2035.
- 3. Ellis S, Tsiopanis G, Lad T. Risks of the ‘Sunshine pill’ – a case of hypervitaminosis D. Clin Med2018;18:311–3.doi:10.7861/ clinmedicine.18-4-311.
- 4. Marcinowska-Suchowierska E, KupiszUrbanska M, Lukaszkiewicz J et al Vitamin D toxicity - a clinical perspective. Front Endocrinol 2018;9:550.doi:10.3389/ fendo.2018.00550pmid:http://www.ncbi.nlm. nih.gov/pubmed/30294301.
- 5. Joshi R. Hypercalcemia due to hypervitaminosis D: report of seven patients. J Trop Pediatr 2009;55:396–8.doi:10.1093/tropej/ fmp020pmid:http://www.ncbi.nlm.nih.gov/ pubmed/.
Data Sharing Statement
There are no additional data available.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Acknowledgements
Information not provided.
Conflicts of Interest
The authors report no conflicts of interest in this work.
About this article
Cite this article
Saini S, Yadav A, Arora S, et al. A rare case of hypercalcemia without any underlying disease. Ind J Emerg Med. 2024;10(3):163-6.
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| July 29, 2024 | August 17, 2024 | September 10, 2024 |
DOI: https://doi.org/10.21088/ijem.2395.311X.10324.10
Keywords
HypercalcemiaVitamin DCalcium supplementsPTHSearch for Similar Articles
Similar Articles
- Crossroads of Industrial Chemistry and Clinical Toxicology: A Rare Case of Orga...
- A Tale of Double Vision
- Incidental Diagnosis of Graves’ Disease in a Patient Presenting with Influenza:...
- Avulsion Fracture Hidden in X-Ray Detected by Point-of-Care Ultrasound in a Youn...
- Disseminated Deep Neck Space Infection in an Immunocompetent Adult: A Case Repor...
Article Level Metrics
Last UpdatedWednesday 17 June 2026, 12:38:29 (IST)
2146
Accesses
21
735
00
Citations
NA
NA
NA
Download citation
Article Keywords
Keyword Highlighting
Highlight selected keywords in the article text.
Timeline
| Received | July 29, 2024 |
| Accepted | August 17, 2024 |
| Published | September 10, 2024 |
licence
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
